Involvement of circulating inflammatory factors in prognosis and risk of cardiovascular disease

J Mol Cell Cardiol. 2019 Jul:132:110-119. doi: 10.1016/j.yjmcc.2019.05.010. Epub 2019 May 15.

Abstract

Cardiovascular disease (CVD) is an inflammatory disease that different factors play a crucial role in the development of clinical outcome of this disease. Inflammation could have effects on initiation, progression, and clinical complications of CVD. Previous studies have indicated that delineating the underlying mechanisms of inflammatory factors involved in this disease should be considerably beneficial both as predictive markers and targets for advancement of appropriate therapeutic approaches in offsetting development and progression of cardiovascular complications. Mechanisms of inflammatory factors involved in CVD combined with the development of atherosclerosis, reperfusion injury, and myocardial infarction caused by changes in processes such as endothelial cells function and hemostasis can contribute to the development of clinical outcome in CVD. Therefore, it can be stated that recognition of inflammatory mechanisms involved in this disease can be a promising tool for evaluation of prognosis in CVD patients. In this article, our goal is to evaluate the possible role of changes in the expressions of inflammatory factors in CVD as well as their relationship with prognosis of this disease.

Keywords: Cardiovascular diseases; Diet; Inflammatory factors; Polymorphism; Prognosis.

Publication types

  • Review

MeSH terms

  • Animals
  • Biomarkers
  • Cardiovascular Diseases / blood
  • Cardiovascular Diseases / etiology*
  • Cardiovascular Diseases / pathology
  • Disease Progression
  • Humans
  • Inflammation / complications*
  • Inflammation Mediators / blood*
  • Prognosis
  • Risk Factors

Substances

  • Biomarkers
  • Inflammation Mediators